Suven Pharmaceuticals

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue375.14354.09238.82226.80260.39
Expenses202.68186.44138.25157.29189.33
EBITDA188.16179.94111.5583.0389.00
EBIT177.47168.80101.0771.6473.35
Profit Before Tax172.46167.64100.5769.5071.05
Net Profit130.16124.2974.7352.3653.43
Financial Ratios
Operating Profit Margin51.64%52.30%49.66%39.01%36.55%
Net Profit Margin35.72%36.13%33.27%24.60%21.94%
Earning Per Share (Diluted)5.114.882.942.062.10
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ